These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12611591)

  • 1. Engineered allosteric mutants of the integrin alphaMbeta2 I domain: structural and functional studies.
    McCleverty CJ; Liddington RC
    Biochem J; 2003 May; 372(Pt 1):121-7. PubMed ID: 12611591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AlphaMbeta2 (CD11b/CD18, Mac-1) integrin activation by a unique monoclonal antibody to alphaM I domain that is divalent cation-sensitive.
    Orchekowski RP; Plescia J; Altieri DC; Bajt ML
    J Leukoc Biol; 2000 Nov; 68(5):641-9. PubMed ID: 11073102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational design of an integrin I domain stabilized in the open high affinity conformation.
    Shimaoka M; Shifman JM; Jing H; Takagi J; Mayo SL; Springer TA
    Nat Struct Biol; 2000 Aug; 7(8):674-8. PubMed ID: 10932253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model of the alphaLbeta2 integrin I-domain/ICAM-1 DI interface suggests that subtle changes in loop orientation determine ligand specificity.
    Legge GB; Morris GM; Sanner MF; Takada Y; Olson AJ; Grynszpan F
    Proteins; 2002 Aug; 48(2):151-60. PubMed ID: 12112684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of integrin alpha M beta 2 ligand-binding function by the urokinase-type plasminogen activator receptor.
    Tang ML; Kong LS; Law SK; Tan SM
    Biochem Biophys Res Commun; 2006 Sep; 348(3):1184-93. PubMed ID: 16905120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From crystal clear ligand binding to designer I domains.
    Leitinger B; Hogg N
    Nat Struct Biol; 2000 Aug; 7(8):614-6. PubMed ID: 10932239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetry.
    Crump MP; Ceska TA; Spyracopoulos L; Henry A; Archibald SC; Alexander R; Taylor RJ; Findlow SC; O'Connell J; Robinson MK; Shock A
    Biochemistry; 2004 Mar; 43(9):2394-404. PubMed ID: 14992576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rolling adhesion of alphaL I domain mutants decorrelated from binding affinity.
    Pepper LR; Hammer DA; Boder ET
    J Mol Biol; 2006 Jun; 360(1):37-44. PubMed ID: 16813834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational regulation of integrin structure and function.
    Shimaoka M; Takagi J; Springer TA
    Annu Rev Biophys Biomol Struct; 2002; 31():485-516. PubMed ID: 11988479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the alphaI domain in ligand binding by integrin alphaEbeta7.
    Corps EM; Robertson A; Dauncey MJ; Kilshaw PJ
    Eur J Immunol; 2003 Sep; 33(9):2599-608. PubMed ID: 12938236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identity of the amino acid residues involved in C3bi binding to the I-domain supports a mosaic model to explain the broad ligand repertoire of integrin alpha M beta 2.
    Ustinov VA; Plow EF
    Biochemistry; 2005 Mar; 44(11):4357-64. PubMed ID: 15766265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for vinculin activation at sites of cell adhesion.
    Bakolitsa C; Cohen DM; Bankston LA; Bobkov AA; Cadwell GW; Jennings L; Critchley DR; Craig SW; Liddington RC
    Nature; 2004 Jul; 430(6999):583-6. PubMed ID: 15195105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence gamma 377-395(P2), but not gamma 190-202(P1), is the binding site for the alpha MI-domain of integrin alpha M beta 2 in the gamma C-domain of fibrinogen.
    Ugarova TP; Lishko VK; Podolnikova NP; Okumura N; Merkulov SM; Yakubenko VP; Yee VC; Lord ST; Haas TA
    Biochemistry; 2003 Aug; 42(31):9365-73. PubMed ID: 12899623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extracellular domains of ErbB3 retain high ligand binding affinity at endosome pH and in the locked conformation.
    Kani K; Park E; Landgraf R
    Biochemistry; 2005 Dec; 44(48):15842-57. PubMed ID: 16313187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of unliganded and inhibitor complexes of W168F, a Loop6 hinge mutant of Plasmodium falciparum triosephosphate isomerase: observation of an intermediate position of loop6.
    Eaazhisai K; Balaram H; Balaram P; Murthy MR
    J Mol Biol; 2004 Oct; 343(3):671-84. PubMed ID: 15465054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic control of allosteric antagonism of leukocyte function antigen-1 and intercellular adhesion molecule-1 interaction.
    Nam K; Maiorov V; Feuston B; Kearsley S
    Proteins; 2006 Aug; 64(2):376-84. PubMed ID: 16705652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential activation of LFA-1 and Mac-1 ligand binding domains.
    Walters SE; Tang RH; Cheng M; Tan SM; Law SK
    Biochem Biophys Res Commun; 2005 Nov; 337(1):142-8. PubMed ID: 16199219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiconformational states in phosphoglycerate dehydrogenase.
    Bell JK; Grant GA; Banaszak LJ
    Biochemistry; 2004 Mar; 43(12):3450-8. PubMed ID: 15035616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition from rolling to firm adhesion can be mimicked by extension of integrin alphaLbeta2 in an intermediate affinity state.
    Salas A; Shimaoka M; Phan U; Kim M; Springer TA
    J Biol Chem; 2006 Apr; 281(16):10876-82. PubMed ID: 16505487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics.
    Song J; Laskowski M; Qasim MA; Markley JL
    Biochemistry; 2003 Jun; 42(21):6380-91. PubMed ID: 12767219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.